Gian Luigi Gessa

Gian Luigi Gessa

Auto-generated profile, based on publicly available information

Gian Luigi Gessa

B.B. Brodie' Department of Neuroscience, University of Cagliari, via Porcell, 4, 09124 Cagliari, Italy

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1998 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GGGian Luigi Gessa
Gian Luigi Gessa
MCMaria Antonietta Casu
Maria Antonietta Casu
GCGiovanna Carta
Giovanna Carta
MMMaria Stefania Mascia
Maria Stefania Mascia

2 May 2005 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
PDPaola Devoto
Paola Devoto
GFGiovanna Flore
Giovanna Flore
PSPierluigi Saba
Pierluigi Saba
MFMauro Fà
Mauro Fà
GGGian Luigi Gessa
Gian Luigi Gessa
Background: Previous studies by our group suggest that extracellular dopamine (DA) and noradrenaline (NA) may be co-released from noradrenergic nerve terminals in the cerebral cortex. We recently demonstrated that the concomitant release of DA and NA could be elicited in the cerebral cortex by electrical stimulation of the locus coeruleus (LC). This study analyses the effect of both single train and repeated electrical stimulation of LC on NA and DA release in the medial prefrontal cortex (mPFC), occipital cortex (Occ), and caudate nucleus. To rule out possible stressful effects of electrical stimulation, experiments were performed on chloral hydrate anaesthetised rats. Results: Twenty min electrical stimulation of the LC, with burst type pattern of pulses, increased NA and DA both in the mPFC and in the Occ. NA in both cortices and DA in the mPFC returned to baseline within 20 min after the end of the stimulation period, while DA in the Occ reached a maximum increase during 20 min post-stimulation and remained higher than baseline values at 220 min post-stimulation. Local perfusion with tetrodotoxin (TTX, 10 μM) markedly reduced baseline NA and DA in the mPFC and Occ and totally suppressed the effect of electrical stimulation in both areas. A sequence of five 20 min stimulations at 20 min intervals were delivered to the LC. Each stimulus increased NA to the same extent and duration as the first stimulus, whereas DA remained elevated at the time next stimulus was delivered, so that baseline DA progressively increased in the mPFC and Occ to reach about 130 and 200% the initial level, respectively. In the presence of the NA transport (NAT) blocker desipramine (DMI, 100 μM), multiple LC stimulation still increased extracellular NA and DA levels. Electrical stimulation of the LC increased NA levels in the homolateral caudate nucleus, but failed to modify DA level. Conclusion: The results confirm and extend that LC stimulation induces a concomitant release of DA and NA in the mPFC and Occ. The different time-course of LC-induced elevation of DA and NA suggests that their co-release may be differentially controlled.

1 October 2019 in Pharmacological Research
Verified
Journal Article
Closed access
CPClaudia Pisanu
Claudia Pisanu
Flavia FranconiFlavia Franconi
Flavia Franconi
GGGian Luigi Gessa
Gian Luigi Gessa
SMSergio Mameli
Sergio Mameli
GPGiovanni Maria Pisanu
Giovanni Maria Pisanu
RARoberta Agabio
Roberta Agabio

6 December 2004 in Alcohol and Alcoholism
Verified
Journal Article
Open access
PDF file
GGGian Luigi Gessa
Gian Luigi Gessa
SSSalvatore Serra
Salvatore Serra
GVGiovanni Vacca
Giovanni Vacca
MCMauro A. M. Carai
Mauro A. M. Carai
GCGiancarlo Colombo
Giancarlo Colombo
Aims: The present study investigated the effect of the newly synthesized cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and the motivational properties of alcohol in selectively bred Sardinian alcohol-preferring (sP) rats. Methods and Results: In Experiment 1, the repeated administration of SR147778 (0.3–3 mg/kg twice daily, i.p.) specifically suppressed the acquisition of alcohol drinking behaviour in alcohol-naive rats exposed to the two-bottle ‘alcohol vs water’ choice regimen for 24 h/day. In Experiment 2, an acute administration of SR147778 (2.5–10 mg/kg, i.p.) specifically reduced alcohol intake in alcohol-experienced rats that were given alcohol and water under the two-bottle choice regimen in daily sessions of 4 h. In Experiment 3, an acute administration of SR147778 (0.3–3 mg/kg, i.p.) suppressed the ‘alcohol deprivation effect’, i.e. the extra-intake of alcohol occurring after a period of alcohol abstinence. In Experiment 4, an acute administration of SR147778 (0.3–3 mg/kg, i.p.) specifically suppressed the extinction responding for alcohol, i.e. the maximal number of lever responses reached in the absence of alcohol in rats trained to lever-press for alcohol (measure of the motivational properties of alcohol). In Experiment 5, the combination of 3 mg/kg of SR147778 (i.p.) and 0.5 g/kg of alcohol (i.p.), a dose comparable with those usually consumed by sP rats in each drinking binge, failed to induce any conditioned taste aversion. Conclusion: Taken together, these results extend to SR147778 the anti-alcohol profile of the prototype cannabinoid CB1 receptor antagonist, rimonabant (SR141716), and strengthen the hypothesis that the cannabinoid CB1 receptor is part of the neural substrate mediating alcohol intake and the motivational properties of alcohol.

1 May 1997 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GGGian Luigi Gessa
Gian Luigi Gessa
MMMaria Stefania Mascia
Maria Stefania Mascia
MCMaria Antonietta Casu
Maria Antonietta Casu
GCGiovanna Carta
Giovanna Carta

1 January 2000
Verified
Journal Article
Closed access
GCGiancarlo Colombo
Giancarlo Colombo
RAR Agabio
R Agabio
MCM A Carai
M A Carai
CLC Lobina
C Lobina
MPM Pani
M Pani
GGG L Gessa
G L Gessa